Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Open Forum Infectious Diseases|February 3, 2025
Defining Fulminant <i>Clostridioides difficile</i> Infections: Assessing the Utility of Hypotension as a Diagnostic CriterionHubert C Chua, Taryn A Eubank, Allen Lee, et al.
Anaerobe|March 1, 2022
Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settingsJinhee Jo, Anne J Gonzales-Luna, Chris K Lancaster, et al.
Frontiers in Endocrinology|November 7, 2025
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers impact on the gut microbiome: a systematic reviewElisabeth M Wang, Abdulwhab Shremo Msdi, Vy N Quach, et al.
Antimicrobial Agents and Chemotherapy|February 16, 2024
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of <i>Clostridioides difficile</i>Eugénie Bassères, Taryn A Eubank, Khurshida Begum, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 24, 2022
Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysisJinhee Jo, Truc T Tran, Nicholas D Beyda, et al.
Journal of Pharmacy Practice|September 19, 2022
Significant Publications on Infectious Diseases Pharmacotherapy in 2021Nhi Nguyen, Hubert C Chua, Ty Drake, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trialJinhee Jo, Travis J Carlson, Chenlin Hu, et al.
The Journal of Infectious Diseases|October 13, 2025
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile RiskHossaena Ayele, Jinhee Jo, Khurshida Begum, et al.
The Journal of Infectious Diseases|December 5, 2023
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy VolunteersJinhee Jo, Chenlin Hu, Khurshida Begum, et al.
Journal of Patient-Reported Outcomes|May 14, 2022
Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of lifeRichard L Hengel, Claudia P Schroeder, Jinhee Jo, et al.
Pageof 3